US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Parabilis Medicines

39.47

+0.46001.18%

Post-market: 39.470.00000.00%16:10 EDT

Volume:500.11K

Turnover:19.41M

Market Cap:4.89B

PE:-1.68

High:40.00

Open:39.15

Low:37.88

Close:39.01

52wk High:41.49

52wk Low:24.51

Shares:124.00M

Float Shares:33.50M

Volume Ratio:1.26

T/O Rate:1.49%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-23.4458

EPS(LYR):-60.0402

ROE:--

ROA:--

PB:4.67

PE(LYR):-0.66

Loading ...

Overview Company News Filings

Parabilis Medicines Initiated at Buy by B of a Securities

Parabilis Medicines Inc : Evercore Isi Initiates Coverage with Outperform Rating

THOMSON REUTERS

Analyst Initiates Buy on Parabilis, Citing First-in-Class Wnt Inhibitor Zolucatidine and Strong Cash Runway

Michael Schmidt Initiates Buy on Parabilis Medicines, Citing Helicon Platform and Zolucatetide as Key Value Drivers with $40 Price Target

U.S. Research Roundup-east West Bancorp, First Citizens Bancshares, UMB Financial

Parabilis Medicines Inc : Guggenheim Initiates Coverage with Buy Rating; Target Price $40

THOMSON REUTERS

Major Investor Makes Bold Move in Parabilis Medicines, Inc. Stock

Soleus Capital’s Guy Levy Acquires $10 Million of Parabilis Medicines Common Shares

Parabilis Medicines Files Form 3 Initial Beneficial Ownership Statement for Guy Levy

Parabilis Medicines director Alan Sebulsky reports PBLS common share purchase worth $812,401.11

Parabilis Medicines director Alan Sebulsky reports purchase of 12,500 common shares for $250,000

Parabilis Medicines Closes Initial Public Offering

MT Newswires Live

Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

THOMSON REUTERS

Parabilis Medicines off highs, but still up over 50% from IPO price

Movement Alert｜Parabilis Medicines Rises 49.15% in Regular Trading, IPO Debuts with 10x Oversubscription

BUZZ-U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner

BUZZ-Drug developer Parabilis Medicines surges in Nasdaq debut

Stock Track | Parabilis Medicines Soars 66.75% Intraday on Successful IPO Pricing Above Expectations

NASDAQ TRADE HALT IPO SECURITY RELEASED FOR QUOTATION AT 11:12 AM

NASDAQ TRADE HALT REASON NOT AVAILABLE AT 09:30 AM

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/PBLS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBLS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBLS\",,,,,undefined,":{"symbol":"PBLS","market":"US","secType":"STK","nameCN":"Parabilis Medicines","latestPrice":39.47,"timestamp":1788292800000,"preClose":39.01,"halted":0,"volume":500111,"hourTrading":{"tag":"盘后","latestPrice":39.47,"preClose":39.47,"latestTime":"16:10 EDT","volume":447,"amount":17643.09,"timestamp":1788293404935,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.011791848244040013,"floatShares":33500000,"shares":124000000,"eps":-23.44581,"marketStatus":"Post-Mkt","change":0.46,"latestTime":"09-01 16:13:14 EDT","open":39.15,"high":40,"low":37.88,"amount":19409432.93775,"amplitude":0.054345,"askPrice":40,"askSize":1,"bidPrice":38,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-23.44581,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788307200000},"marketStatusCode":4,"adr":0,"listingDate":1781064000000,"exchange":"NASDAQ","adjPreClose":39.01,"preHourTrading":{"tag":"盘前","latestPrice":38.01,"preClose":39.01,"latestTime":"09:06 EDT","volume":23,"amount":900.719928,"timestamp":1788267979579,"change":-1,"changeRate":-0.025634,"amplitude":0.039221},"postHourTrading":{"tag":"盘后","latestPrice":39.47,"preClose":39.47,"latestTime":"16:10 EDT","volume":447,"amount":17643.09,"timestamp":1788293404935,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.258405,"impliedVol":0.4768,"impliedVolPercentile":0.1212},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBLS\",,,,,undefined,":{"symbol":"PBLS","floatShares":33500000,"roa":"--","roe":"--","lyrEps":-60.040199,"volumeRatio":1.258405,"shares":124000000,"dividePrice":0,"high":40,"amplitude":0.054345,"preClose":39.01,"low":37.88,"week52Low":24.51,"pbRate":"4.67","psRate":"33069.46","week52High":41.4899,"institutionHeld":0,"latestPrice":39.47,"committee":0.980198,"eps":-23.44581,"divideRate":0,"volume":500111,"delay":0,"ttmEps":-23.44581,"open":39.15,"prevYearClose":20,"prevWeekClose":39.11,"prevMonthClose":39.01,"prevQuarterClose":27.37,"fiveDayClose":39.23,"twentyDayClose":35.9,"sixtyDayClose":20},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBLS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"PBLS","fiscalQuarterEnding":"2026/06","expectedEps":-0.16,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-2.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBLS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBLS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1786939200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PBLS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PBLS","date":"2026-08-31","current":-1.683456,"percent":0.272727,"low":-31.159897,"twenty":-28.505108,"median":-25.67089,"eighty":-22.938881,"high":-15.535256,"avg":-25.814203,"sd":2.99884,"marketCap":4831385016},"quantilePoints":[{"date":"2026-06-12","current":-23.423744,"twenty":-24.021896,"median":-23.423744,"eighty":-18.690651,"marketCap":3580998591},{"date":"2026-06-18","current":-21.681158,"twenty":-23.280127,"median":-22.147598,"eighty":-21.001488,"marketCap":3314593719},{"date":"2026-06-26","current":-21.956025,"twenty":-22.933884,"median":-22.426629,"eighty":-21.561216,"marketCap":3356615076},{"date":"2026-07-02","current":-23.122126,"twenty":-23.423744,"median":-22.77646,"eighty":-21.681158,"marketCap":3534887500},{"date":"2026-07-10","current":-25.287743,"twenty":-24.420664,"median":-22.938881,"eighty":-21.956025,"marketCap":3865964860},{"date":"2026-07-17","current":-24.204934,"twenty":-24.912925,"median":-23.706058,"eighty":-22.147598,"marketCap":3700426180},{"date":"2026-07-24","current":-27.328421,"twenty":-25.279414,"median":-24.204934,"eighty":-22.705661,"marketCap":4177941603},{"date":"2026-07-31","current":-26.886968,"twenty":-25.665893,"median":-24.321545,"eighty":-22.738979,"marketCap":4110452756},{"date":"2026-08-07","current":-29.635636,"twenty":-26.527142,"median":-24.625564,"eighty":-22.753971,"marketCap":4530666328},{"date":"2026-08-14","current":-29.710599,"twenty":-28.289622,"median":-24.912925,"eighty":-22.788954,"marketCap":4542126698},{"date":"2026-08-21","current":-28.671719,"twenty":-28.53843,"median":-25.283578,"eighty":-22.890572,"marketCap":4889445639},{"date":"2026-08-28","current":-28.461644,"twenty":-28.506557,"median":-25.662561,"eighty":-22.933884,"marketCap":4853620999},{"date":"2026-08-31","current":-28.331252,"twenty":-28.505108,"median":-25.67089,"eighty":-22.938881,"marketCap":4831385016}],"updateTime":1788293594166},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBLS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649234623","title":"Parabilis Medicines Initiated at Buy by B of a Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2649234623","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649234623?lang=en_us&edition=fundamental","pubTime":"2026-07-06 18:39","pubTimestamp":1783334340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PBLS/analyst-ratings(END) Dow Jones NewswiresJuly 06, 2026 06:39 ET","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649238956","title":"Parabilis Medicines Inc : Evercore Isi Initiates Coverage with Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2649238956","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649238956?lang=en_us&edition=fundamental","pubTime":"2026-07-06 18:13","pubTimestamp":1783332826,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nFWN4380BU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649282316","title":"Analyst Initiates Buy on Parabilis, Citing First-in-Class Wnt Inhibitor Zolucatidine and Strong Cash Runway","url":"https://stock-news.laohu8.com/highlight/detail?id=2649282316","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649282316?lang=en_us&edition=fundamental","pubTime":"2026-07-06 17:56","pubTimestamp":1783331761,"startTime":"0","endTime":"0","summary":"Charles Zhu, an analyst from LifeSci Capital, has initiated a new Buy rating on Parabilis Medicines, Inc. (PBLS). Charles Zhu has given his Buy rat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-initiates-buy-on-parabilis-citing-first-in-class-wnt-inhibitor-zolucatidine-and-strong-cash-runway-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-initiates-buy-on-parabilis-citing-first-in-class-wnt-inhibitor-zolucatidine-and-strong-cash-runway-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649628495","title":"Michael Schmidt Initiates Buy on Parabilis Medicines, Citing Helicon Platform and Zolucatetide as Key Value Drivers with $40 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2649628495","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649628495?lang=en_us&edition=fundamental","pubTime":"2026-07-06 17:55","pubTimestamp":1783331756,"startTime":"0","endTime":"0","summary":"Parabilis Medicines, Inc. (PBLS) has received a new Buy rating, initiated by Guggenheim analyst, Michael Schmidt. Michael Schmidt has given his Buy...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/michael-schmidt-initiates-buy-on-parabilis-medicines-citing-helicon-platform-and-zolucatetide-as-key-value-drivers-with-40-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/michael-schmidt-initiates-buy-on-parabilis-medicines-citing-helicon-platform-and-zolucatetide-as-key-value-drivers-with-40-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649642573","title":"U.S. Research Roundup-east West Bancorp, First Citizens Bancshares, UMB Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2649642573","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649642573?lang=en_us&edition=fundamental","pubTime":"2026-07-06 16:21","pubTimestamp":1783326117,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-East West Bancorp, First Citizens Bancshares, UMB FinancialJuly 6 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nL4N4380GG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DAN","CVS","CLOD","BIIB","JNJ","SM","SMOG","CFR","BEG","DLTR","PEP","FRBT","SPAM","CBSH","ABBV","FCNCA","UNHW","UNH","EROC","PJP","RSPS","BE","EWBC","REGN","S","GILD","FDS","CRWD","UMBF","STZ","OZK","GDX","FTXH","OKTA","MRK","ADP","USB","RGLD","CCB","FLG","PBLS","PFE","PSCE","NEM","FAST","AVA","HBAN","SOC","PNFP","IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649861053","title":"Parabilis Medicines Inc : Guggenheim Initiates Coverage with Buy Rating; Target Price $40","url":"https://stock-news.laohu8.com/highlight/detail?id=2649861053","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649861053?lang=en_us&edition=fundamental","pubTime":"2026-07-06 10:51","pubTimestamp":1783306283,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nFWN438001:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647586277","title":"Major Investor Makes Bold Move in Parabilis Medicines, Inc. Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2647586277","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647586277?lang=en_us&edition=fundamental","pubTime":"2026-06-30 10:05","pubTimestamp":1782785118,"startTime":"0","endTime":"0","summary":"New insider activity at Parabilis Medicines, Inc. ( ($PBLS) ) has taken place on June 29, 2026. Significant shareholder Guy Levy has made a major m...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-investor-makes-bold-move-in-parabilis-medicines-inc-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-investor-makes-bold-move-in-parabilis-medicines-inc-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647370775","title":"Soleus Capital’s Guy Levy Acquires $10 Million of Parabilis Medicines Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2647370775","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647370775?lang=en_us&edition=fundamental","pubTime":"2026-06-29 22:41","pubTimestamp":1782744119,"startTime":"0","endTime":"0","summary":"Soleus Capital’s Guy Levy acquires $10 million of Parabilis Medicines common sharesParabilis Medicines Form 4 showed 10% owner Guy Levy increased indirect common stock holdings through affiliated Sole","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL7jZ3x5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Soleus Capital’s Guy Levy Acquires $10 Million of Parabilis Medicines Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647370717","title":"Parabilis Medicines Files Form 3 Initial Beneficial Ownership Statement for Guy Levy","url":"https://stock-news.laohu8.com/highlight/detail?id=2647370717","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647370717?lang=en_us&edition=fundamental","pubTime":"2026-06-29 22:39","pubTimestamp":1782743942,"startTime":"0","endTime":"0","summary":"Parabilis Medicines files Form 3 initial beneficial ownership statement for Guy LevyParabilis Medicines Form 3 filed for Guy Levy, flagged as a 10% owner, tied to Soleus Capital-managed entities.Repor","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL4dC7Hp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644793725","title":"Parabilis Medicines director Alan Sebulsky reports PBLS common share purchase worth $812,401.11","url":"https://stock-news.laohu8.com/highlight/detail?id=2644793725","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644793725?lang=en_us&edition=fundamental","pubTime":"2026-06-17 06:20","pubTimestamp":1781648403,"startTime":"0","endTime":"0","summary":"Parabilis Medicines director Alan Sebulsky reported purchases of 17,500 common shares at weighted-average prices of USD 25.9978 to USD 27.6696.Holdings reported as indirectly owned through Apothecary Capital LLC rose to 30,000 common shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Parabilis Medicines Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL32s7BS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Parabilis Medicines director Alan Sebulsky reports PBLS common share purchase worth $812,401.11","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643895467","title":"Parabilis Medicines director Alan Sebulsky reports purchase of 12,500 common shares for $250,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2643895467","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643895467?lang=en_us&edition=fundamental","pubTime":"2026-06-16 05:28","pubTimestamp":1781558909,"startTime":"0","endTime":"0","summary":"Parabilis Medicines director Alan Sebulsky disclosed an indirect purchase of 12,500 common shares at USD 20 each.The stake is held through Apothecary Capital LLC, leaving 12,500 shares beneficially owned indirectly following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Parabilis Medicines Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL1BK30r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Parabilis Medicines director Alan Sebulsky reports purchase of 12,500 common shares for $250,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642234620","title":"Parabilis Medicines Closes Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2642234620","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642234620?lang=en_us&edition=fundamental","pubTime":"2026-06-12 04:36","pubTimestamp":1781210188,"startTime":"0","endTime":"0","summary":"Parabilis Medicines (PBLS) said Thursday it has closed its upsized initial public offering of about 38.5 million shares, including the full exercise of an overallotment option, at $20.00 each.The clin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1974910355.USD","REGN","LU0053666078.USD","LU0889565916.HKD","LU0109394709.USD","LU2362541273.HKD","LU0114720955.EUR","LU2237438978.USD","LU2106854487.HKD","LU0823434583.USD","BK4588","LU0320765992.SGD","IPOS","LU0882574055.USD","LU2023250504.SGD","LU2468319806.SGD","LU0823416689.USD","LU0823434740.USD","LU0289739699.SGD","BK4585","LU1917777945.USD","LU0058720904.USD","BK4139","LU2362540622.SGD","PBLS","LU2362541513.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642823190","title":"Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2642823190","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642823190?lang=en_us&edition=fundamental","pubTime":"2026-06-12 04:05","pubTimestamp":1781208311,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nFWN42J0OB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642001478","title":"Parabilis Medicines off highs, but still up over 50% from IPO price","url":"https://stock-news.laohu8.com/highlight/detail?id=2642001478","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642001478?lang=en_us&edition=fundamental","pubTime":"2026-06-11 02:20","pubTimestamp":1781115610,"startTime":"0","endTime":"0","summary":"The shares in afternoon trading are up $10.67 from the $20.00 offer price to $30.67. Published first on TheFly – the ultimate source for real-time,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/parabilis-medicines-off-highs-but-still-up-over-50-from-ipo-price-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/parabilis-medicines-off-highs-but-still-up-over-50-from-ipo-price-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBLS","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158068339","title":"Movement Alert｜Parabilis Medicines Rises 49.15% in Regular Trading, IPO Debuts with 10x Oversubscription","url":"https://stock-news.laohu8.com/highlight/detail?id=1158068339","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158068339?lang=en_us&edition=fundamental","pubTime":"2026-06-11 02:04","pubTimestamp":1781114651,"startTime":"0","endTime":"0","summary":"On June 10, Parabilis Medicines surged 49.15% in regular trading, trading at $29.90/share with trading volume of approximately $102 million. The stock made its public market debut after pricing its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642478617","title":"BUZZ-U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner","url":"https://stock-news.laohu8.com/highlight/detail?id=2642478617","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642478617?lang=en_us&edition=fundamental","pubTime":"2026-06-11 01:37","pubTimestamp":1781113032,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarnerWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nL6N42I0OG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBLS","BWA","ILMN","MSC","AMZN","DVN","CNC","HOOZ","APA","CASY","ODFL","AU","QCOM","CRMT","EROC","MOH","UHS","JCI","NEM","NKE","00200","CGEM","XOMX","CAVA","IIPR","AMZW","AMZD","TNGX","HOOD","KIM","SMCI","CBRL","HOOX","CVX","CCTG","CHWY","CPOP","XOMZ","SKIL","NWMX","AKR","STTK","JILL","WTI","GNRC","SI","FDX","BE","XOM","UPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642478315","title":"BUZZ-Drug developer Parabilis Medicines surges in Nasdaq debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2642478315","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642478315?lang=en_us&edition=fundamental","pubTime":"2026-06-11 01:19","pubTimestamp":1781111991,"startTime":"0","endTime":"0","summary":"BUZZ-Drug developer Parabilis Medicines surges in Nasdaq debut** Shares of Parabilis Medicines PBLS.O jump 43% in Nasdaq debut** The drug developer's stock opened at $33.35 apiece vs $20 IPO price** The Cambridge, Massachusetts-based PBLS sold 33.5 million shares in an upsized offering above its marketed range of $17 and $19 apiece to raise $670 million** Parabilis, whose pipeline is focused on various cancers and tumors, was co-founded in 2015 by longtime Harvard professor Greg Verdine** Separately, PBLS agreed to sell $75 million worth of shares in a concurrent private placement to Regeneron Pharmaceuticals REGN.O ** \"The upsize  a strong signal that investors are increasingly willing to fund ambitious biotechs again, especially when those companies come with external validation and a path into late-stage development\" - IPOX Research Associate Lukas Muehlbauer** \"Innovative biotech IPOs can also catch a premium with M&A remaining highly active as an important exit route for recent li","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nL6N42I14U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","LU2237438978.USD","LU0053666078.USD","LU2023250504.SGD","LU0823434740.USD","REGN","LU0823416689.USD","LU2089984988.USD","LU0109394709.USD","LU2362541273.HKD","LU0823434583.USD","LU0058720904.USD","LU0889565916.HKD","LU1974910355.USD","LU2468319806.SGD","LU0320765992.SGD","LU0114720955.EUR","LU0882574055.USD","LU1917777945.USD","PBLS","LU0289739699.SGD","BK4585","LU2362540622.SGD","LU2106854487.HKD","NUVL","BK4539","LU2362541513.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139874515","title":"Stock Track | Parabilis Medicines Soars 66.75% Intraday on Successful IPO Pricing Above Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=1139874515","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139874515?lang=en_us&edition=fundamental","pubTime":"2026-06-11 00:46","pubTimestamp":1781110004,"startTime":"0","endTime":"0","summary":"Shares of Parabilis Medicines (PBLS) soared 66.75% during intraday trading on Wednesday, following its debut on the Nasdaq Global Select Market.The significant surge is attributed to the company's...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642422432","title":"NASDAQ TRADE HALT  IPO SECURITY RELEASED FOR QUOTATION AT 11:12 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2642422432","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642422432?lang=en_us&edition=fundamental","pubTime":"2026-06-10 23:12","pubTimestamp":1781104353,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  IPO SECURITY RELEASED FOR QUOTATION AT 11:12 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nAQN2M2Z41:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642429011","title":"NASDAQ TRADE HALT  REASON NOT AVAILABLE AT 09:30 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2642429011","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642429011?lang=en_us&edition=fundamental","pubTime":"2026-06-10 21:30","pubTimestamp":1781098247,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  REASON NOT AVAILABLE AT 09:30 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nAQN2M2VD1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBLS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":46,"code":"91000000","status":"200"}]}}